Development of Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV)-Mediated Prodrug Activator Gene Therapy in Human Glioma Models

被引：0
|
作者：
Collins, Sara A. [1 ]
Inagaki, Akihito Inagaki [1 ]
Tai, Chien-Kuo [2 ]
Logg, Christopher R. [3 ]
Searle, Peter F. [4 ]
Tangney, Mark [5 ]
Kasahara, Noriyuki [1 ,6 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Natl Chung Cheng Univ, Dept Biomed Sci, Chiayi, Taiwan
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[4] Univ Birmingham, Sch Canc Sci, CR UK Canc Ctr, Birmingham, W Midlands, England
[5] Univ Coll Cork UCC, Cork Canc Res Ctr, Cork, Ireland
[6] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
347
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV) Mediated Prodrug Activator Gene Therapy in Human Glioma Models
    Collins, Sara A.
    Logg, Christopher R.
    Inagaki, Akihito
    Kamijima, Shuichi
    Lehouritis, Panos
    Searle, Peter F.
    Tangney, Mark
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2015, 23 : S171 - S171
  • [2] leDEVELOPMENT OF RETROVIRAL REPLICATING VECTORS ENCODING SEQUENCE-OPTIMIZED NITROREDUCTASE FOR PRODRUG ACTIVATOR GENE THERAPY IN HUMAN GLIOMA MODELS
    Collins, Sara
    Inagaki, Akihito
    Tai, Chien-Kuo
    Logg, Christopher R.
    Searle, Peter
    Tangney, Mark
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2020, 22 : 96 - 96
  • [3] RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA
    Collins, Sara
    Logg, Christopher
    Inagaki, Akihito
    Kamijima, Shuichi
    Lehouritis, Panos
    Searle, Peter
    Tangney, Mark
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2014, 16
  • [4] Retroviral Replicating Vector (RRV)-Mediated Prodrug Activator Gene Therapy With Codon-Optimized Nitroreductase
    Collins, S. A.
    Logg, C. R.
    Inagaki, A.
    Hiraoka, K.
    Kamijima, S.
    Herman, K.
    Searle, P. F.
    Tangney, M.
    Kasahara, N.
    HUMAN GENE THERAPY, 2012, 23 (10) : A92 - A92
  • [5] RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED THYMIDINE KINASE
    Inagaki, Akihito
    Hiraoka, Kei
    Bogan, Brooke
    Logg, Christopher R.
    Kamijima, Shuichi
    Sato, Makoto
    Ostertag, Derek
    Perez, Omar D.
    Robbins, Joan M.
    Jolly, Douglas J.
    Gruber, Harry E.
    Kasahara, Noriyuki
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 277 - 277
  • [6] PRECLINICAL EVALUATION OF PRODRUG ACTIVATOR GENE THERAPY BY RETROVIRAL REPLICATING VECTORS (RRV) IN HUMAN AND MOUSE GLIOMA MODELS
    Hiraoka, Kei
    Inagaki, Akihito
    Logg, Christopher R.
    Kamijima, Shuichi
    Ostertag, Derek
    Perez, Omar D.
    Gruber, Harry E.
    Jolly, Douglas J.
    Robbins, Joan M.
    Kasahara, Noriyuki
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 264 - 265
  • [7] Therapeutic Efficacy of Retroviral Replicating Vector (RRV) -Mediated Prodrug Activator Gene Therapy for Pancreatic Cancer
    Inoko, Kazuho
    Hiraoka, Kei
    Inagaki, Akihito
    Takahashi, Mizuna
    Kushibiki, Toshihiro
    Hontani, Koji
    Takano, Hironobu
    Sato, Shoki
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Jolly, Douglas J.
    Kasahara, Noriyuki
    Hirano, Satoshi
    MOLECULAR THERAPY, 2016, 24 : S266 - S266
  • [8] Retroviral Replicating Vector (RRV)-Mediated Prodrug-Activator Gene Therapy Transcriptionally Targeted to Prostate Cancer
    Kamijima, Shuichi
    Kimura, Takahiro
    Haga, Kazunori
    Hiraoka, Kei
    Inagaki, Akihito
    Takahashi, Masamichi
    Logg, Christopher R.
    Kao, Chinghai
    Bochner, Bernard H.
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2013, 21 : S29 - S29
  • [9] ENHANCING RETROVIRAL REPLICATING VECTOR-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH ENGINEERED HUMAN MESENCHYMAL STEM CELLS IN ANIMAL MODELS OF GLIOMA
    Tam, Quincy
    NEURO-ONCOLOGY, 2013, 15 : 215 - 215
  • [10] Retroviral replicating vector-mediated prodrug activator gene therapy in an experimental model of human osteosarcoma
    Kubo, S.
    Takagi-Kimura, M.
    Kasahara, N.
    HUMAN GENE THERAPY, 2017, 28 (12) : A28 - A29
12345